Cargando…

Artemisinin-Based Antimalarial Drug Therapy: Molecular Pharmacology and Evolving Resistance

The molecular pharmacology of artemisinin (ART)-based antimalarial drugs is incompletely understood. Clinically, these drugs are used in combination with longer lasting partner drugs in several different artemisinin combination therapies (ACTs). ACTs are currently the standard of care against Plasmo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Heller, Laura E., Roepe, Paul D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6631165/ https://www.ncbi.nlm.nih.gov/pubmed/31167396 http://dx.doi.org/10.3390/tropicalmed4020089

Ejemplares similares

Drug resistance genomics of the antimalarial drug artemisinin
por: Winzeler, Elizabeth A, et al.
Publicado: (2014)

Preventing antimalarial drug resistance with triple artemisinin-based combination therapies
por: Nguyen, Tran Dang, et al.
Publicado: (2023)

Artemisinin Antimalarials: Preserving the “Magic Bullet”
por: Maude, Richard J, et al.
Publicado: (2010)

Artemisinin-based antimalarial research: application of biotechnology to the production of artemisinin, its mode of action, and the mechanism of resistance of Plasmodium parasites
por: Muangphrom, Paskorn, et al.
Publicado: (2016)

Transmission of Artemisinin-Resistant Malaria Parasites to Mosquitoes under Antimalarial Drug Pressure
por: Witmer, Kathrin, et al.
Publicado: (2020)

Evolution of Plasmodium falciparum antimalarial drug resistance markers post-adoption of artemisinin-based combination therapies in Yaounde, Cameroon
por: Niba, Peter Thelma Ngwa, et al.
Publicado: (2023)

Artemisinin Combination Therapy: A Good Antimalarial, but Is the Dose Right?
por: Garner, Paul
Publicado: (2013)

Estimating antimalarial drugs consumption in Africa before the switch to artemisinin-based combination therapies (ACTs)
por: Kindermans, Jean-Marie, et al.
Publicado: (2007)

Anticancer Effect of AntiMalarial Artemisinin Compounds
por: Das, AK
Publicado: (2015)

Protecting future antimalarials from the trap of resistance: Lessons from artemisinin-based combination therapy (ACT) failures
por: Erhunse, Nekpen, et al.
Publicado: (2021)

DNA binding by the antimalarial compound artemisinin
por: Slavkovic, Sladjana, et al.
Publicado: (2022)

Stable Production of the Antimalarial Drug Artemisinin in the Moss Physcomitrella patens
por: Khairul Ikram, Nur Kusaira Binti, et al.
Publicado: (2017)

Quantifying the pharmacology of antimalarial drug combination therapy
por: Hastings, Ian M., et al.
Publicado: (2016)

Antimalarial and anticancer properties of artesunate and other artemisinins: current development
por: Khanal, Pitambar
Publicado: (2021)

Antimalarial Drug Resistance and Novel Targets for Antimalarial Drug Discovery
por: Shibeshi, Melkamu Adigo, et al.
Publicado: (2020)

Antimalarial pharmacology and therapeutics of atovaquone
por: Nixon, Gemma L., et al.
Publicado: (2013)

Proteomic analysis of Artemisia annua – towards elucidating the biosynthetic pathways of the antimalarial pro-drug artemisinin
por: Bryant, Laura, et al.
Publicado: (2015)

A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistance
por: O'Neill, Paul M., et al.
Publicado: (2017)

Immunoregulation by Artemisinin and Its Derivatives: A New Role for Old Antimalarial Drugs
por: Qiu, Feifei, et al.
Publicado: (2021)

In vitro growth competition experiments that suggest consequences of the substandard artemisinin epidemic that may be accelerating drug resistance in P. falciparum malaria
por: Hassett, Matthew R., et al.
Publicado: (2021)

Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré
por: Bonnet, Maryline, et al.
Publicado: (2007)

The threat of antimalarial drug resistance
por: Hanboonkunupakarn, Borimas, et al.
Publicado: (2016)

Antimalarial Activity of C-10 Substituted Triazolyl Artemisinin
por: Park, Gab-Man, et al.
Publicado: (2017)

Synthesis and Antimalarial Activity of Novel Dihydro-Artemisinin Derivatives
por: Liu, Yang, et al.
Publicado: (2011)

Molecular and physiologic basis of quinoline drug resistance in Plasmodium falciparum malaria
por: Roepe, Paul D
Publicado: (2009)

Evaluation of the Quality of Artemisinin-Based Antimalarial Medicines Distributed in Ghana and Togo
por: Osei-Safo, Dorcas, et al.
Publicado: (2014)

World Antimalarial Resistance Network I: Clinical efficacy of antimalarial drugs
por: Price, Ric N, et al.
Publicado: (2007)

Split dosing of artemisinins does not improve antimalarial therapeutic efficacy
por: White, N. J., et al.
Publicado: (2017)

Antimalarial drug resistance: An overview
por: Antony, Hiasindh Ashmi, et al.
Publicado: (2016)

World Antimalarial Resistance Network (WARN) II: In vitro antimalarial drug susceptibility
por: Bacon, David J, et al.
Publicado: (2007)

World Antimalarial Resistance Network (WARN) IV: Clinical pharmacology
por: Barnes, Karen I, et al.
Publicado: (2007)

Five Years of Antimalarial Resistance Marker Surveillance in Gaza Province, Mozambique, Following Artemisinin-Based Combination Therapy Roll Out
por: Raman, Jaishree, et al.
Publicado: (2011)

Resistance to Artemisinin Combination Therapies (ACTs): Do Not Forget the Partner Drug!
por: Nsanzabana, Christian
Publicado: (2019)

FABRICATION AND EVALUATION OF SMART NANOCRYSTALS OF ARTEMISININ FOR ANTIMALARIAL AND ANTIBACTERIAL EFFICACY.
por: Shah, Syed Muhammad Hassan, et al.
Publicado: (2016)

Direct Activation of TRPC3 Channels by the Antimalarial Agent Artemisinin
por: Urban, Nicole, et al.
Publicado: (2020)

A database of antimalarial drug resistance
por: Sibley, Carol Hopkins, et al.
Publicado: (2006)

Assessing Antimalarial Efficacy in a Time of Change to Artemisinin-Based Combination Therapies: The Role of Médecins Sans Frontières
por: Guthmann, Jean-Paul, et al.
Publicado: (2008)

Efficacy and safety of artemisinin-based combination therapy, and molecular markers for artemisinin and piperaquine resistance in Mainland Tanzania
por: Kakolwa, Mwaka A., et al.
Publicado: (2018)

The molecular basis of antimalarial drug resistance in Plasmodium vivax
por: Buyon, Lucas E., et al.
Publicado: (2021)

Antitumor Activity of Artemisinin and Its Derivatives: From a Well-Known Antimalarial Agent to a Potential Anticancer Drug
por: Crespo-Ortiz, Maria P., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_f3dn6p9c8serum3hmtqpgaefd1